Press Release on Strategic AI Collaboration with AZMed

Date: October 22, 2026 Ref. No.: KDL/SE/059/2026-27 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400051 Scrip Code: 543328 NSE Symbol: KRSNAA Dear Sir/Madam, Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Press Release on strategic AI collaboration with AZmed Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III thereto, please find enclosed herewith the press release of Krsnaa Diagnostics Limited (“the Company”) titled “Krsnaa Diagnostics Announces Strategic AI Collaboration with Global Radiology AI Innovator AZmed, Creating a Platform for Greater Reporting Efficiency and Scalable Growth”. The said press release is also being made available on the website of the Company at https://krsnaadiagnostics.com/investors/ You are requested to take the above on record. Thanking you Yours faithfully, For Krsnaa Diagnostics Limited Sujoy Sudipta Bose Company Secretary and Compliance Officer PRESS RELEASE Krsnaa Diagnostics Announces Strategic AI Collaboration with Global Radiology AI Innovator AZmed, Creating a Platform for Greater Reporting Efficiency and Scalable Growth Krsnaa Diagnostics Limited, one of India’s leading diagnostic service providers, today announced a collaboration with AZmed, a globally recognised medical imaging company specialising in artificial intelligence (AI) solutions for radiology. The collaboration will evaluate AZmed’s AZtrauma solution, part of its Rayvolve AI suite, for the detection and triage of fractures, joint effusions, and dislocations on X-rays. The collaboration marks an important step in Krsnaa Diagnostics’ strategy to leverage advanced AI technologies that can strengthen its radiology operations, enhance reporting efficiency and build capacity for future growth. With one of India’s largest X-ray reporting operations, processing more than 5 million X-rays annually, Krsnaa is well positioned to evaluate the potential of AI-assisted radiology at scale. By exploring the integration of globally developed AI capabilities into its extensive diagnostic network, Krsnaa aims to create opportunities for improved operational productivity, greater utilisation of radiologist capacity and enhanced scalability as diagnostic volumes grow. Over time, these efficiencies could provide additional headroom to support business expansion and contribute to unlock operating leverage, subject to successful evaluation, regulatory approvals and implementation. Where scale meets innovation Krsnaa Diagnostics delivers diagnostic imaging, pathology and teleradiology services across 19 states and union territories through 190+ CT and MRI centres, 2,000+ X-ray centres, 212 pathology laboratories and more than 4,700 patient collection centres. Its PPP-led model delivers services at rates over 70% below prevailing market rates, bringing quality diagnostics to millions of patients in tier II and tier III cities. Krsnaa also operates World’s first American College of Radiology (ACR)-recognised Teleradiology HUB outside US Borders in Pune, which provides round-the-clock reporting to government hospitals, medical colleges and community health centres nationwide. AZmed is considered to be amongst the most recognised names in radiology AI worldwide. Founded in Paris in 2018, the company’s Rayvolve solution became the first AI software to receive CE marking for fracture detection on X-rays in 2019, and AZmed has since secured multiple 510(k) clearances from the US Food and Drug Administration (FDA). Its technology has analysed more than 15 million medical images globally. Leadership Perspectives “Healthcare AI presents a significant opportunity to transform the future of diagnostic services. By integrating advanced AI technologies into our high-volume radiology operations, we aim to unlock operating leverage, enhance productivity, expand reporting capacity and build a more scalable operating model enabling Krsnaa to serve more patients with best-in-class technology at highly affordable prices.” said Mr. Yash Mutha, Managing Director, Krsnaa Diagnostics Limited. “With approximately 5 million X-rays reported every year, Krsnaa has the scale and operational experience to evaluate how AI-assisted radiology can contribute to more efficient workflows. Our collaboration with AZmed allows us to explore the potential of globally developed technology within the Indian healthcare ecosystem, while maintaining the central role of our radiologists in clinical decision-making,” Dr. Madhuri Ghate, Vice President - Radiology, Krsnaa Diagnostics Limited. Julien Vidal, CEO of AZmed, said, “India represents a significant opportunity for the advancement of AI- enabled radiology. Krsnaa Diagnostics’ extensive reach and reporting capabilities make it a valuable partner for bringing our leading AI solutions for medical imaging into high-volume diagnostic workflows. We look forward to working together to support radiologists, improve workflow efficiency, and advance diagnostic imaging practices.” About Krsnaa Diagnostics Limited Krsnaa Diagnostics Limited is one of India’s leading diagnostic service providers, delivering radiology, pathology and teleradiology services through a broad network of diagnostic facilities. The company has a significant presence in public-private partnership healthcare models, supporting access to diagnostic services across urban, semi-urban and underserved markets. Krsnaa continues to explore technology- led opportunities to strengthen diagnostic delivery, operational efficiency and access to quality healthcare. About AZmed Founded in 2018, AZmed is a European MedTech company developing AI solutions for medical imaging. Its Rayvolve AI suite includes FDA-cleared and CE-marked tools, while its Rayscan line is CE-marked. Used by more than 2,500 healthcare facilities worldwide, AZmed’s solutions are designed to support diagnostic consistency and operational efficiency in medical imaging. Forward-Looking Statements This press release contains certain forward-looking statements, including statements regarding the collaboration, the evaluation of AI-assisted reporting and its potential benefits. Such statements are based on the Company’s current expectations and are subject to risks and uncertainties, including the outcome of the evaluation, receipt of regulatory approvals, contractual and data-related requirements, technological performance and market conditions, which could cause actual results to differ materially from those expressed or implied.